FDA 483 - Patanjali Ayurved Limited - September 30, 2021

Patanjali Ayurved Limited in Haridwar, India, was inspected by the FDA from September 27-30, 2021, and received a Form 483 with six observations. The inspection revealed significant deficiencies in quality control, manufacturing records, product specifications, foreign material protection, and laboratory controls for dietary supplements. These issues indicate a lack of adherence to good manufacturing practices.